We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novartis AG's epilepsy drug Trileptal has a new warning about life-threatening
skin reactions reported by patients who took the medicine, the company and the
Food and Drug Administration said on Tuesday.
Chugai Pharmaceutical announced that "Forerunner Pharma Research Co., Ltd."
(FPR) was jointly established with Mitsui & Co., Ltd. and Central Institute
for Experimental Animals (CIEA).
Novartis Pharma K.K. and Asahi Kasei Pharma jointly announced that they have
agreed to collaborate in promoting Voltaren, a nonsteroidal anti-inflammatory
agent.
Sankyo said it has sealed a three-year joint research contract with unlisted
MerLion Pharmaceuticals Pte of Singapore aimed at developing drugs made from
compounds of natural substances.
Europe's generic drugs industry
has slammed European plans to offer an additional six months of patent life
to branded medicine makers who develop products for children.
Leading South African HIV/AIDS lobby the Treatment Action Campaign
(TAC), trade unions, doctors' groups and religious bodies have condemned allegedly
bogus products supplied by a US-based vitamins distributor, the Dr Rath Health
Foundation.
OEP, the Hungarian National Health Insurance Fund which reimburses
the majority of selling prices on the country's drugs list, is to expand and
simplify its drug categories system.
Johnson & Johnson said on Tuesday it will acquire Peninsula Pharmaceuticals
Inc., a privately held biotechnology company focused on developing antibiotics,
in a cash deal valued at about $245 million.